Syndax Pharmaceuticals, Inc. · NASDAQ:SNDX
Kynam Capital Management, LP reported a 9.98% stake in Syndax Pharmaceuticals, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Kynam Capital Management, LP reported a 9.98% stake in Syndax Pharmaceuticals, Inc., 8,520,000 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 9.98%
- Shares
- 8,520,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Kynam Capital Management, LP | 9.98% | 8,520,000 |
| Kynam Capital Management GP, LLC | 9.98% | 8,520,000 |
| Yue Tang | 9.98% | 8,520,000 |
Source
Related
- Syndax Pharmaceuticals, Inc.
- Kynam Capital Management, LP
- Syndax Pharmaceuticals, Inc. shareholders
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Metzger Michael A · Jul 9, 2026
- Form 4 · Botwood Nicholas A.J. · Jun 12, 2026
- Form 4 · Goldan Keith A. · Jun 2, 2026
- Form 4 · Metzger Michael A · Jun 2, 2026